Rohto Pharmaceutical Co.,Ltd. (TYO: 4527)
Japan
· Delayed Price · Currency is JPY 3,571.00
-16.00 (-0.45%)
Oct 10, 2024, 10:04 AM JST
Rohto Pharmaceutical Co.,Ltd. Cash Flow Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | - | 41,518 | 34,290 | 27,953 | 23,006 | 21,730 | Upgrade
|
| Depreciation & Amortization | - | 8,687 | 7,801 | 7,673 | 6,748 | 6,937 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 348 | 1,338 | 892 | 1,691 | 1,009 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | 798 | 285 | 798 | -750 | -425 | Upgrade
|
| Loss (Gain) on Equity Investments | - | 289 | -56 | -143 | -396 | 1,192 | Upgrade
|
| Other Operating Activities | - | -10,218 | -6,995 | -10,347 | -9,508 | -6,598 | Upgrade
|
| Change in Accounts Receivable | - | -6,787 | -7,560 | -30 | 2,464 | -4,304 | Upgrade
|
| Change in Inventory | - | -4,029 | -6,105 | -3,061 | 3,188 | 892 | Upgrade
|
| Change in Accounts Payable | - | 1,679 | 1,716 | 3,323 | -2,811 | -900 | Upgrade
|
| Change in Other Net Operating Assets | - | 1,960 | 6,210 | 192 | -3,624 | -493 | Upgrade
|
| Operating Cash Flow | - | 34,245 | 30,924 | 27,250 | 20,008 | 19,040 | Upgrade
|
| Operating Cash Flow Growth | - | 10.74% | 13.48% | 36.20% | 5.08% | -12.44% | Upgrade
|
| Capital Expenditures | - | -7,979 | -8,473 | -10,267 | -8,721 | -5,586 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 272 | 109 | 12 | 597 | 2,128 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,203 | -1,516 | -5,755 | Upgrade
|
| Sale (Purchase) of Intangibles | - | -933 | -1,435 | -1,061 | -1,583 | -847 | Upgrade
|
| Investment in Securities | - | -7,376 | -3,299 | -3,652 | 1,844 | 768 | Upgrade
|
| Other Investing Activities | - | 230 | 178 | 128 | - | 112 | Upgrade
|
| Investing Cash Flow | - | -16,317 | -13,176 | -16,406 | -10,237 | -9,405 | Upgrade
|
| Short-Term Debt Issued | - | 656 | - | 1,273 | - | - | Upgrade
|
| Long-Term Debt Issued | - | 1,605 | 220 | 9,450 | 2,883 | 5,032 | Upgrade
|
| Total Debt Issued | - | 2,261 | 220 | 10,723 | 2,883 | 5,032 | Upgrade
|
| Short-Term Debt Repaid | - | - | -1,341 | - | -169 | -2,649 | Upgrade
|
| Long-Term Debt Repaid | - | -3,484 | -8,761 | -3,133 | -1,880 | -714 | Upgrade
|
| Total Debt Repaid | - | -3,484 | -10,102 | -3,133 | -2,049 | -3,363 | Upgrade
|
| Net Debt Issued (Repaid) | - | -1,223 | -9,882 | 7,590 | 834 | 1,669 | Upgrade
|
| Dividends Paid | - | -5,475 | -4,676 | -3,422 | -2,965 | -3,078 | Upgrade
|
| Other Financing Activities | - | -7,086 | -1,641 | -698 | -216 | -194 | Upgrade
|
| Financing Cash Flow | - | -13,784 | -16,199 | 3,470 | -2,347 | -1,603 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 4,703 | 5,236 | 4,335 | 96 | -781 | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 23 | 1 | 1 | 68 | 68 | Upgrade
|
| Net Cash Flow | - | 8,870 | 6,786 | 18,650 | 7,588 | 7,319 | Upgrade
|
| Free Cash Flow | - | 26,266 | 22,451 | 16,983 | 11,287 | 13,454 | Upgrade
|
| Free Cash Flow Growth | - | 16.99% | 32.20% | 50.47% | -16.11% | -12.23% | Upgrade
|
| Free Cash Flow Margin | - | 9.70% | 9.41% | 8.51% | 6.23% | 7.14% | Upgrade
|
| Free Cash Flow Per Share | - | 114.80 | 98.13 | 74.23 | 49.33 | 58.81 | Upgrade
|
| Cash Interest Paid | - | 200 | 247 | 228 | 143 | 130 | Upgrade
|
| Cash Income Tax Paid | - | 9,970 | 6,937 | 8,731 | 7,771 | 6,617 | Upgrade
|
| Levered Free Cash Flow | - | 15,301 | 12,450 | 11,698 | 8,861 | 11,469 | Upgrade
|
| Unlevered Free Cash Flow | - | 15,423 | 12,604 | 11,853 | 8,952 | 11,547 | Upgrade
|
| Change in Net Working Capital | 1,985 | 9,456 | 6,250 | 2,112 | 1,159 | 3,258 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.